Literature DB >> 17334341

Primer: Demystifying risk--understanding and communicating medical risks.

Cynthia S Crowson1, Terry M Therneau, Eric L Matteson, Sherine E Gabriel.   

Abstract

Assessments of risk are a critical part of the practice of evidence-based medicine. Comprehension of various risk measures, such as absolute risk, relative risk, attributable risk, odds ratio, and hazard ratio, is essential to understand the medical literature, and to communicate health risks effectively. Complex risk measures, including number needed to treat and survival estimates that are adjusted for competing risks, are often misunderstood. Communication of these concepts to patients can be a challenge. The patient's perception of risk stems not only from the way risks are stated, but also from family history, personal experiences, cultural norms, and beliefs. A multifaceted approach to risk communication that uses both qualitative and quantitative assessments of risk, and addresses the timing and permanence of risks, is necessary to ensure the patient understands the potential risks. Successful communication involves interaction with the patient to understand the patient's perspective and to aid in personalized decision-making. In the face of uncertainty, making a provisional decision with a plan to review it later can be a good strategy. Verifying the patient's comprehension can help ensure that the decisions reached are informed and acceptable.

Entities:  

Mesh:

Year:  2007        PMID: 17334341     DOI: 10.1038/ncprheum0397

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  7 in total

Review 1.  Re-conceptualizing risk in genetic counseling: implications for clinical practice.

Authors:  Jehannine C Austin
Journal:  J Genet Couns       Date:  2010-01-30       Impact factor: 2.537

2.  The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

Authors:  Cynthia S Crowson; Eric L Matteson; Elena Myasoedova; Clement J Michet; Floranne C Ernste; Kenneth J Warrington; John M Davis; Gene G Hunder; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-03

3.  Descriptive and numeric estimation of risk for psychotic disorders among affected individuals and relatives: implications for clinical practice.

Authors:  Jehannine C Austin; Catriona Hippman; William G Honer
Journal:  Psychiatry Res       Date:  2012-03-14       Impact factor: 3.222

4.  The Implementation Chasm Hindering Genome-informed Health Care.

Authors:  Kevin B Johnson; Ellen Wright Clayton; Justin Starren; Josh Peterson
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

5.  To know or not to know? Not the only question in familial breast cancer risk communication.

Authors:  C Maddock; D Schrijvers; Mrd Turco; L Marotti; R Sullivan
Journal:  Ecancermedicalscience       Date:  2011-12-13

6.  The Dutch public are positive about the colorectal cancer-screening programme, but is this a well-informed opinion?

Authors:  Linda N Douma; Ellen Uiters; Danielle R M Timmermans
Journal:  BMC Public Health       Date:  2016-11-29       Impact factor: 3.295

Review 7.  What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.

Authors:  R Andrew Moore; Sheena Derry; Henry J McQuay; John Paling
Journal:  Arthritis Res Ther       Date:  2008-02-07       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.